While it's important to feel gratitude for what we've accomplished, it's precisely because of these advancements that we can't put current efforts on cruise control. We've put ourselves on a course where we can save millions of lives every year through targeted global health investments
TB anywhere is TB everywhere. As an airborne disease that can be spread through the simple of act of coughing, our decision makers have an obligation to heed the evidence and ramp up our slowing fight against an ancient disease, before its control spins out of our grasp.
It is vital that we remain positive, even in the face of daunting challenges. This means recognizing progress where it is happening, having faith in the wonderful people of the region, and remaining confident that, if they do what needs to be done, their fight against AIDS can ultimately be won.
This is my call -- from a poor nation to history makers -- to be the generation who can change the course of history. Let's march mercilessly against TB, HIV and malaria. In an age of vaccines, antibiotics and dramatic scientific progress, these diseases can be brought under control.
It is time to commit the resources and energies needed to go the distance. It will take all of us -- governments, donors, civil society, affected communities, and businesses -- to achieve this goal. We must act now to stop people living with HIV from dying of TB.
Preventing a problem in the first place is the Holy Grail to mitigating some of the world's greatest challenges. Future generations will pay the price for each year we are delayed in making new TB vaccines available for the world.
Though more than 3,500 people worldwide died of TB today, you won't see it reported in headlines of any major American newspaper. Neither will you see that March 24 is World TB Day simply because for many Americans it is a disease that doesn't hit home, but this could quickly change.
For well over a century, South Africa miners, their families, and communities have been decimated by tuberculosis. But, the current momentum in the region suggests that we may have had good reason to be hopeful.
Any truly effective response against either disease will have to be comprehensive: one that scales up existing programs for prevention and care while quickly rolling out new biomedical tools and strategies to reduce transmission -- especially vaccines.
As the world's attention has been fixated on the fight against HIV and AIDS, something ironic and perverse has happened. We have failed to invest enough resources to mount an effective fight against tuberculosis (TB), the number-one killer of people living with HIV.
This week donors are meeting to discuss the Global Fund's progress in fighting the three killer diseases: AIDS, TB and malaria. Looking at the future, one thing is clear: we need sufficient funds and we need to spend them right.
Amongst the bayonets and bravado, there was no discussion about how either candidate would use the office of the president to address the top global health challenges. Neglecting to head off threats from superbugs now will lead to calamitous consequences later.